retatrutide vs tirzepatide muscle loss Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Recent JAMA Article on Muscle

Their findings reflected broader issues in science communication, where simplified and emotionally resonant narratives often overshadow nuanced scientific reporting

AcevesCMendietaIAnguianoBDelgado-GonzlezE

Oral Supplements Answer: Injections deliver glutathione directly into the bloodstream or muscle, while oral supplements must survive digestion first, where much of the tripeptide is broken down before it can be absorbed

The drug will be available as a sterile solution for subcutaneous injection in pre-filled pens in 2 mg and 4 mg strengths

In Canada, GLP-1 medications are already a significant driver of drug plan spending an Alberta Blue Cross report that reviewed new drug and supplemental submissions made to Health Canada in 2025 named such treatments as a major cost of employer-sponsored drug plans, particularly as the drugs are approved for treatment of more conditions

JAMA 308(23):24892496